SIGNACOXX Capsule is a specialized non-steroidal anti-inflammatory drug (NSAID) designed to manage pain and inflammation with enhanced selectivity for the cyclooxygenase-2 (COX-2) enzyme. The formulation is commonly used in the treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute pain caused by musculoskeletal injuries, dental procedures, and postoperative recovery. The capsule offers potent analgesic and anti-inflammatory action while minimizing gastrointestinal irritation often associated with conventional NSAIDs that inhibit both COX-1 and COX-2 enzymes.
The key advantage of SIGNACOXX lies in its selective COX-2 inhibition mechanism, which allows it to alleviate pain and inflammation without significantly affecting COX-1 activity, thereby reducing the risk of gastric ulcers, bleeding, and renal complications. This targeted action makes it an optimal choice for patients with chronic inflammatory conditions who require long-term pain management with a favorable gastrointestinal safety profile.
Manufactured by Bluepill Express, SIGNACOXX Capsule is produced under stringent quality controls in WHO-GMP and ISO-certified pharmaceutical plants. The product is developed using high-purity active pharmaceutical ingredients (APIs), advanced encapsulation technology, and internationally compliant packaging. Bluepill Express ensures batch-to-batch consistency, pharmacopoeial-grade materials, and export-standard documentation, making SIGNACOXX suitable for global distribution, including to regulated markets.
The formulation of SIGNACOXX provides rapid onset of action with sustained relief, enabling improved patient compliance and daily function restoration. It is often prescribed by rheumatologists, orthopedic surgeons, and pain management specialists as part of multi-modal therapy. Additionally, it serves as an effective alternative for patients intolerant to non-selective NSAIDs or those with a history of gastrointestinal disorders.
Each capsule is encased in a pharmaceutical-grade gelatin shell, designed for rapid dissolution and systemic availability. The packaging includes blister strips or HDPE containers with clear labeling for dosage guidance, batch traceability, and export documentation including COA, MSDS, stability data, and product inserts tailored for individual market compliance.
SIGNACOXX Capsule is offered through Bluepill Express’s third-party manufacturing solutions with full-service options including product development, private labeling, customized packaging, regulatory support, and global logistics. Whether for hospital supply, pharmacy chains, or private retail branding, the formulation is suitable for both acute prescriptions and long-term chronic care regimens.
Description provided by bluepill express.
FIEO Registered
Export Ready
